The University of Southampton
University of Southampton Institutional Repository

Intranasal treatments for allergic rhinitis in preschool- and school-age children: network meta-analysis

Intranasal treatments for allergic rhinitis in preschool- and school-age children: network meta-analysis
Intranasal treatments for allergic rhinitis in preschool- and school-age children: network meta-analysis

Background: intranasal medications are considered a first-line treatment of allergic rhinitis (AR). Objective: We performed a systematic review and network meta-analysis (NMA) comparing the efficacy and safety of intranasal antihistamines (INAH), intranasal corticosteroids (INCS), and their fixed combination (INAH+INCS) for the treatment of AR in children. 

Methods: we searched four electronic bibliographic and three clinical trial databases for randomized controlled trials assessing the use of INAH, INCS, and INAH+INCS in children (aged <18 years) with seasonal or perennial AR. We performed an NMA on the Total Nasal Symptom Score, Total Ocular Symptom Score, Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), development of adverse events, and withdrawals due to adverse events. We assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation approach for NMA. 

Results: we included 31 studies (12,168 participants). All assessed medication classes were more effective than placebo in improving the Total Nasal Symptom Score. For seasonal AR, INAH+INCS was associated with a higher probability of a clinically relevant improvement in the Total Ocular Symptom Score and RQLQ compared with INCS alone. For the treatment of perennial AR, INCS displayed a higher probability than INAH of meaningfully improving the RQLQ. We found no relevant differences regarding safety outcomes. For most comparisons, the certainty of evidence was deemed moderate or high. 

Conclusions: intranasal medications are effective and safe in the treatment of AR in children, although their efficacy in improving nasal symptoms does not seem to be as high as in adults. Further research is needed because available evidence has provided mixed results depending on the AR type and outcome measures assessed.

Allergic rhinitis, Children, Intranasal antihistamines, Intranasal corticosteroids, Network meta-analysis
2213-2198
2826-2837
Gil-Mata, Sara
85ebf755-f3e3-42c3-a4eb-bf2caee23243
Vieira, Rafael José
66a4766b-336a-4abd-99d2-f0289a0192e5
Borowiack, Ewa
93bc63b6-a414-49a7-b2dd-ef8dae6f3dbd
Sadowska, Ewelina
58b8bdf7-6422-4ddd-b5ee-ffa7d2c4c5dc
Bognanni, Antonio
802b525e-8d76-4848-9f77-cc5c0f349378
Cardoso-Fernandes, António
09f9655e-b464-46f7-b33f-d4136e14910e
Ferreira-Cardoso, Henrique
0caee5a5-175c-458b-aa85-3cd9243e7596
Castro-Teles, João
fdf43924-f22d-4eb9-ad1e-1d12d315f175
Soprani, Juliana
cb5f4aff-639b-4a15-8911-18dd610aa6e3
Pinheiro, Liliane
580458a8-7563-41ce-bb79-0629fa54e4d4
Marques-Cruz, Manuel
8c8c0451-b37d-4958-a371-4bfb1147a827
Campos-Lopes, Miguel
482df076-5a3e-4a59-b9dc-9cc367eb2804
Lourenço-Silva, Nuno
a5877b74-72db-41d8-a539-70bba0155a5d
Ferreira-da-Silva, Renato
9d2c62ad-3e51-400c-9208-a35167e18e44
Bedbrook, Anna
772c167f-f76a-4738-b70e-220e153f27de
Lityńska, Justyna
72764c8b-0b3e-40cf-b578-14ce3f2bad73
Chérrez-Ojeda, Ivan
af109775-1443-4f1a-a795-96d8e9791423
Klimek, Ludger
9ac8a3eb-ac3f-494d-92f3-5cc2637b17d1
Pfaar, Oliver
e3f9b5dc-2e6d-4526-8a61-29024ff1c4b4
Fernandes, Ricardo M.
d9c3de62-729d-44d6-8616-47f5096fd7c2
Fiocchi, Alessandro G.
937ae2ae-5803-4650-af47-4c1bc4123cdd
Giovannini, Mattia
7fc36c50-742a-4a60-b45c-c41aec454707
Larenas-Linnemann, Désirée E.
132d3c9d-018f-4999-a944-a1d856b5bc17
Pham-Thi, Nhân
c27abb54-8160-48ad-a27e-b8a402647fbb
Papadopoulos, Nikolaos G.
bb0da82a-300e-44b9-ba26-3573d81f48be
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Valiulis, Arunas
aa786492-5fcf-42eb-bb12-6e21aa83d540
Yepes-Nuñez, Juan Jose
613a87a9-8da3-4fbe-b96b-81a4eaad24e4
Zuberbier, Torsten
0c26e302-c8de-4e14-a699-a9746692e1ff
Fonseca, João A.
23200eaa-abe6-4043-9f89-33200eebc73e
Schünemann, Holger J.
d57a9844-6cfe-475f-b4a8-fd89104fee4c
Bousquet, Jean
8065d130-faa7-4c8e-bf40-8d2899980c21
Sousa-Pinto, Bernardo
6f16e57f-0979-47af-83de-fbe725438293
ARIA 2024 Guideline Panel
Gil-Mata, Sara
85ebf755-f3e3-42c3-a4eb-bf2caee23243
Vieira, Rafael José
66a4766b-336a-4abd-99d2-f0289a0192e5
Borowiack, Ewa
93bc63b6-a414-49a7-b2dd-ef8dae6f3dbd
Sadowska, Ewelina
58b8bdf7-6422-4ddd-b5ee-ffa7d2c4c5dc
Bognanni, Antonio
802b525e-8d76-4848-9f77-cc5c0f349378
Cardoso-Fernandes, António
09f9655e-b464-46f7-b33f-d4136e14910e
Ferreira-Cardoso, Henrique
0caee5a5-175c-458b-aa85-3cd9243e7596
Castro-Teles, João
fdf43924-f22d-4eb9-ad1e-1d12d315f175
Soprani, Juliana
cb5f4aff-639b-4a15-8911-18dd610aa6e3
Pinheiro, Liliane
580458a8-7563-41ce-bb79-0629fa54e4d4
Marques-Cruz, Manuel
8c8c0451-b37d-4958-a371-4bfb1147a827
Campos-Lopes, Miguel
482df076-5a3e-4a59-b9dc-9cc367eb2804
Lourenço-Silva, Nuno
a5877b74-72db-41d8-a539-70bba0155a5d
Ferreira-da-Silva, Renato
9d2c62ad-3e51-400c-9208-a35167e18e44
Bedbrook, Anna
772c167f-f76a-4738-b70e-220e153f27de
Lityńska, Justyna
72764c8b-0b3e-40cf-b578-14ce3f2bad73
Chérrez-Ojeda, Ivan
af109775-1443-4f1a-a795-96d8e9791423
Klimek, Ludger
9ac8a3eb-ac3f-494d-92f3-5cc2637b17d1
Pfaar, Oliver
e3f9b5dc-2e6d-4526-8a61-29024ff1c4b4
Fernandes, Ricardo M.
d9c3de62-729d-44d6-8616-47f5096fd7c2
Fiocchi, Alessandro G.
937ae2ae-5803-4650-af47-4c1bc4123cdd
Giovannini, Mattia
7fc36c50-742a-4a60-b45c-c41aec454707
Larenas-Linnemann, Désirée E.
132d3c9d-018f-4999-a944-a1d856b5bc17
Pham-Thi, Nhân
c27abb54-8160-48ad-a27e-b8a402647fbb
Papadopoulos, Nikolaos G.
bb0da82a-300e-44b9-ba26-3573d81f48be
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Valiulis, Arunas
aa786492-5fcf-42eb-bb12-6e21aa83d540
Yepes-Nuñez, Juan Jose
613a87a9-8da3-4fbe-b96b-81a4eaad24e4
Zuberbier, Torsten
0c26e302-c8de-4e14-a699-a9746692e1ff
Fonseca, João A.
23200eaa-abe6-4043-9f89-33200eebc73e
Schünemann, Holger J.
d57a9844-6cfe-475f-b4a8-fd89104fee4c
Bousquet, Jean
8065d130-faa7-4c8e-bf40-8d2899980c21
Sousa-Pinto, Bernardo
6f16e57f-0979-47af-83de-fbe725438293

Gil-Mata, Sara, Vieira, Rafael José and Borowiack, Ewa , ARIA 2024 Guideline Panel (2025) Intranasal treatments for allergic rhinitis in preschool- and school-age children: network meta-analysis. Journal of Allergy and Clinical Immunology: In Practice, 13 (10), 2826-2837. (doi:10.1016/j.jaip.2025.07.004).

Record type: Article

Abstract

Background: intranasal medications are considered a first-line treatment of allergic rhinitis (AR). Objective: We performed a systematic review and network meta-analysis (NMA) comparing the efficacy and safety of intranasal antihistamines (INAH), intranasal corticosteroids (INCS), and their fixed combination (INAH+INCS) for the treatment of AR in children. 

Methods: we searched four electronic bibliographic and three clinical trial databases for randomized controlled trials assessing the use of INAH, INCS, and INAH+INCS in children (aged <18 years) with seasonal or perennial AR. We performed an NMA on the Total Nasal Symptom Score, Total Ocular Symptom Score, Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), development of adverse events, and withdrawals due to adverse events. We assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation approach for NMA. 

Results: we included 31 studies (12,168 participants). All assessed medication classes were more effective than placebo in improving the Total Nasal Symptom Score. For seasonal AR, INAH+INCS was associated with a higher probability of a clinically relevant improvement in the Total Ocular Symptom Score and RQLQ compared with INCS alone. For the treatment of perennial AR, INCS displayed a higher probability than INAH of meaningfully improving the RQLQ. We found no relevant differences regarding safety outcomes. For most comparisons, the certainty of evidence was deemed moderate or high. 

Conclusions: intranasal medications are effective and safe in the treatment of AR in children, although their efficacy in improving nasal symptoms does not seem to be as high as in adults. Further research is needed because available evidence has provided mixed results depending on the AR type and outcome measures assessed.

Text
PURE_ID_284596840 - Accepted Manuscript
Restricted to Repository staff only until 15 October 2026.
Request a copy

More information

Accepted/In Press date: 2 July 2025
e-pub ahead of print date: 14 July 2025
Published date: October 2025
Keywords: Allergic rhinitis, Children, Intranasal antihistamines, Intranasal corticosteroids, Network meta-analysis

Identifiers

Local EPrints ID: 506120
URI: http://eprints.soton.ac.uk/id/eprint/506120
ISSN: 2213-2198
PURE UUID: cd83681b-5307-459b-b851-d4c931b59b79
ORCID for Graham Roberts: ORCID iD orcid.org/0000-0003-2252-1248

Catalogue record

Date deposited: 28 Oct 2025 18:31
Last modified: 29 Oct 2025 02:40

Export record

Altmetrics

Contributors

Author: Sara Gil-Mata
Author: Rafael José Vieira
Author: Ewa Borowiack
Author: Ewelina Sadowska
Author: Antonio Bognanni
Author: António Cardoso-Fernandes
Author: Henrique Ferreira-Cardoso
Author: João Castro-Teles
Author: Juliana Soprani
Author: Liliane Pinheiro
Author: Manuel Marques-Cruz
Author: Miguel Campos-Lopes
Author: Nuno Lourenço-Silva
Author: Renato Ferreira-da-Silva
Author: Anna Bedbrook
Author: Justyna Lityńska
Author: Ivan Chérrez-Ojeda
Author: Ludger Klimek
Author: Oliver Pfaar
Author: Ricardo M. Fernandes
Author: Alessandro G. Fiocchi
Author: Mattia Giovannini
Author: Désirée E. Larenas-Linnemann
Author: Nhân Pham-Thi
Author: Nikolaos G. Papadopoulos
Author: Graham Roberts ORCID iD
Author: Arunas Valiulis
Author: Juan Jose Yepes-Nuñez
Author: Torsten Zuberbier
Author: João A. Fonseca
Author: Holger J. Schünemann
Author: Jean Bousquet
Author: Bernardo Sousa-Pinto
Corporate Author: ARIA 2024 Guideline Panel

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×